Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEAT: Fosamprenavir vs Nelfinavir in ART-Naive HIV-1
NCT00008554Phase 3Unknown
- Sponsor
- GSK
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fosamprenavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Status: unknown.
02
Drugs
fosamprenavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00008554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008554.